<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05128240</url>
  </required_header>
  <id_info>
    <org_study_id>P237921</org_study_id>
    <nct_id>NCT05128240</nct_id>
  </id_info>
  <brief_title>Nutritional Study of Fish Oil in Skin Quality in Healthy Women</brief_title>
  <acronym>OPTIHUD</acronym>
  <official_title>A Randomised, Two-armed, Double-blinded Nutritional Study of Fish Oil on Skin Quality in Healthy Women</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Epax Norway AS</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Møreforsking AS</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Epax Norway AS</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The skin acts as a barrier against the external environment and prevents water loss from the&#xD;
      body. Aging is a natural process leading to changes in the skin and fish oil has been shown&#xD;
      to prevent inflammation, hyperpigmentation and UV-damage. This pilot study will determine&#xD;
      skin characteristics after intervention with north atlantic fish oil.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Women will be recruited to a placebo or fish oil group and be examined at pre- and post for&#xD;
      skin quality parameters such as wrinkles, fine lines and trans-epithelial water loss.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 23, 2021</start_date>
  <completion_date type="Anticipated">March 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 20, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Placebo controlled, double blind intervention study.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
    <masking_description>Interventions are given as 1g bovine capsules of equal size, weight and appearance, and provided in identical bottles with a coded label.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Determine the change in skin quality of healthy women after supplementation with fish oil compared to corn oil</measure>
    <time_frame>3 months</time_frame>
    <description>Changes in quantitative analysis of facial inflammation, wrinkles and fine lines and skin texture will be performed using the VISIA Skin Analysis system. Measurements will be made at baseline and at end of supplementation period.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Determine the change in omega-3 index (%EPA and DHA in red blood cells) after daily intake of 4g of north atlantic fish oil compared to placebo</measure>
    <time_frame>3 months</time_frame>
    <description>Fatty acid profiles will be measured from blood samples using the Omega-quant test</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Skin Health</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>4x1g corn oil capsules</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ceto 10</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>4x1g capsules containing containing broad spectrum marine oil from north atlantic fish</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>1g corn oil capsules</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Ceto 10</intervention_name>
    <description>1g capsules containing oil broad spectrum marine oil from north atlantic fish</description>
    <arm_group_label>Ceto 10</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Healthy women in the age of 30-65&#xD;
&#xD;
        Able to follow the following dietary restriction for 4 months (4 weeks wash-out, 3 months&#xD;
        intervention):&#xD;
&#xD;
          -  Do not take omega-3 supplements&#xD;
&#xD;
          -  do not take supplements containing vitamin A&#xD;
&#xD;
          -  do not take supplements containing collagen&#xD;
&#xD;
          -  try to avoid using skin products containing vitamin A&#xD;
&#xD;
          -  do not undergo skin treatment&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Pregnancy or breast feeding known allergy to seafood skin treatment the last 6 months&#xD;
        planned skin treatment during the study period&#xD;
&#xD;
        -&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Participation is based on self-assessment of gender identity</gender_description>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lisa Midtbø, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Møreforsking AS</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Derek Tobin, PhD</last_name>
    <email>derek.tobin@pelagia.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Møreforsking AS</name>
      <address>
        <city>Ålesund</city>
        <zip>6006</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lise Midtbø, PhD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 4, 2021</study_first_submitted>
  <study_first_submitted_qc>November 16, 2021</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 19, 2021</study_first_posted>
  <last_update_submitted>November 16, 2021</last_update_submitted>
  <last_update_submitted_qc>November 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>skin</keyword>
  <keyword>inflammation</keyword>
  <keyword>wrinkles</keyword>
  <keyword>trans epithelial water loss</keyword>
  <keyword>fish oil</keyword>
  <keyword>LCMUFA</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Data will be presented as collective statistical data. Individual participant data may be shared on request, or if demanded by journals</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

